Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

9.3K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-linked helicases DDX3X and DDX3Y regulate G-quadruplex-associated stress in neurons.

Cell death & disease·2026
Same author

α-Synuclein overexpression increases the tropism of pre-formed fibrils and MSA-patient derived seeds towards oligodendroglia.

Acta neuropathologica communications·2026
Same author

Long-Term Outcomes From a Decade of Donation After Circulatory Death Heart Transplantation in Australia.

JACC. Heart failure·2026
Same author

Limited transmission of cervid prions to nonhuman primates provides insights into the zoonotic potential of chronic wasting disease.

Science advances·2026
Same author

Creutzfeldt-Jakob disease is an Alzheimer's disease-related dementia.

Trends in molecular medicine·2026
Same author

Single-nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy.

Nature communications·2026

Related Experiment Video

Updated: Jun 11, 2025

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

19.6K

Screening of Anti-Prion Compounds Using the Protein Misfolding Cyclic Amplification Technology.

Sandra Pritzkow1, Isaac Schauer1, Ananya Tupaki-Sreepurna1

  • 1Department of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.

Biomolecules
|September 28, 2024
PubMed
Summary

Methylene blue effectively inhibited prion replication across four species using protein misfolding cyclic amplification (PMCA). This technology also aids in screening anti-prion compounds and studying their species-specific activity.

Keywords:
Creutzfeldt-Jakob diseasePMCAprion replicationprionstherapeutic compounds

More Related Videos

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
09:50

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material

Published on: September 29, 2017

13.6K
High-throughput Screening for Protein-based Inheritance in S. cerevisiae
08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

6.3K

Related Experiment Videos

Last Updated: Jun 11, 2025

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

19.6K
Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
09:50

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material

Published on: September 29, 2017

13.6K
High-throughput Screening for Protein-based Inheritance in S. cerevisiae
08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

6.3K

Area of Science:

  • Neurodegenerative diseases
  • Infectious diseases
  • Biochemistry

Background:

  • Prion diseases are fatal neurodegenerative conditions caused by misfolded prion proteins (PrPSc).
  • Protein misfolding cyclic amplification (PMCA) is a key technology for in vitro prion replication and detection.

Purpose of the Study:

  • To evaluate PMCA's utility in screening chemical compounds that inhibit prion replication.
  • To assess the anti-prion activity of selected compounds across different species.

Main Methods:

  • Utilized PMCA to test compounds against prions from human, cattle, cervid, and mouse.
  • Determined the inhibitory concentration 50 (IC50) for effective compounds.

Main Results:

  • Methylene blue completely inhibited prion replication in all tested species.
  • The IC50 for methylene blue against human prions (vCJD) was 7.7 μM.
  • Some compounds exhibited differential inhibitory effects across species.

Conclusions:

  • PMCA is a viable tool for screening anti-prion compounds.
  • PMCA facilitates structure-activity relationship studies for potential prion disease therapeutics.
  • Differential species selectivity of inhibitors can be identified using PMCA.